Structural basis of potent inhibition of the human CAD dihydroorotase domain by 5-aminoorotic acid
Biochemical and Biophysical Research Communications · 2025
DOI: 10.1016/j.bbrc.2025.152804 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2025. Verfasst von Yen-Hua Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Chung Shan Medical University, Taichung City, Taiwan. Hauptthemen laut MEDLINE: Dihydroorotase, Orotic Acid, Enzyme Inhibitors, Oxidoreductases Acting on CH-CH Group Donors. Die Arbeit nennt 44 Literaturangaben. Gefördert von: National Science and Technology Council, Ministry of Science and Technology, Taiwan, Chung Shan Medical University.
Abstract (Originalsprache)
Dihydroorotase (DHOase) catalyzes the reversible conversion of N-carbamoyl-L-aspartate to dihydroorotate in de novo pyrimidine biosynthesis. In humans, DHOase (huDHOase) is part of the CAD enzyme complex and contains a flexible loop that alternates between loop-in and loop-out conformations. Here, we identify 5-aminoorotic acid (5-AOA), previously known as a dihydroorotate dehydrogenase inhibitor, as a potent huDHOase inhibitor. Enzyme assays showed strong inhibition by 5-AOA (IC50 = 9.87 μM) compared with weaker inhibition by 5-fluoroorotic acid (5-FOA; IC50 = 191.59 μM). To elucidate the mechanism, we determined the crystal structures of huDHOase bound to 5-AOA (1.83 Å; PDB ID: 9WIC) and to 5-FOA (1.55 Å; PDB ID: 9WIN) for direct comparison. Structural analysis revealed distinct binding modes: 5-AOA bound in the loop-in conformation, forming extensive stabilizing interactions, whereas 5-FOA bound in the loop-out state with fewer contacts. Consistently, the T1562A mutation decreased the binding affinity of 5-AOA from 18.6 μM to 53.4 μM, an approximately threefold reduction, confirming the role of the loop in inhibitor recognition. These findings establish 5-AOA as a dual inhibitor in pyrimidine biosynthesis and highlight a loop-in binding mechanism for huDHOase inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Chung Shan Medical University, Taichung City, Taiwan.
- Department of Biomedical Sciences, Chung Shan Medical University, Taichung City, Taiwan; The Affiliated Senior High School of National Chung Hsing University, Taichung City, Taiwan.
- Department of Biomedical Sciences, Chung Shan Medical University, Taichung City, Taiwan; Department of Medical Research, Chung Shan Medical University Hospital, Taichung City, Taiwan. Electronic address: cyhuang@csmu.ed…
Förderung
- National Science and Technology Council
- Ministry of Science and Technology, Taiwan
- Chung Shan Medical University
Zitieren
APA
Huang, Y. H., Huang, T. Y., Wang, M. C., & Huang, C. Y. (2025). Structural basis of potent inhibition of the human CAD dihydroorotase domain by 5-aminoorotic acid. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2025.152804
Vancouver
Huang YH, Huang TY, Wang MC, Huang CY. Structural basis of potent inhibition of the human CAD dihydroorotase domain by 5-aminoorotic acid. Biochemical and Biophysical Research Communications. 2025. doi:10.1016/j.bbrc.2025.152804
BibTeX
@article{Huang2025,
author = {Huang, Yen-Hua and Huang, Tsai-Ying and Wang, Man-Cheng and Huang, Cheng-Yang},
title = {Structural basis of potent inhibition of the human CAD dihydroorotase domain by 5-aminoorotic acid},
journal = {Biochemical and Biophysical Research Communications},
year = {2025},
doi = {10.1016/j.bbrc.2025.152804}
}
EUVIMED